Literature DB >> 16006135

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.

Diana Zala1, Alexandra Benchoua, Emmanuel Brouillet, Valérie Perrin, Marie-Claude Gaillard, Anne D Zurn, Patrick Aebischer, Nicole Déglon.   

Abstract

A lentiviral vector expressing a mutant huntingtin protein (htt171-82Q) was used to generate a chronic model of Huntington's disease (HD) in rat primary striatal cultures. In this model, the majority of neurons expressed the transgene so that Western blot analysis and flow cytometry measurement could complement immunohistological evaluation. Mutant huntingtin produced a slowly progressing pathology characterized after 1 month by the appearance of neuritic aggregates followed by intranuclear inclusions, morphological anomalies of neurites, loss of neurofilament 160, increased expression in stress response protein Hsp70, and later loss of neuronal markers such as NeuN and MAP-2. At 2 months post-infection, a significant increase in TUNEL-positive cells confirmed actual striatal cell loss. Interestingly, cortical cultures infected with the same vector showed no sign of neuronal dysfunction despite accumulation of numerous inclusions. We finally examined whether the trophic factors CNTF and BDNF that were found neuroprotective in acute HD models could prevent striatal degeneration in a chronic model. Results demonstrated that both agents were neuroprotective without modifying inclusion formation. The present study demonstrates that viral vectors coding for mutant htt provides an advantageous system for histological and biochemical analysis of HD pathogenesis in primary striatal cultures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006135     DOI: 10.1016/j.nbd.2005.05.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

1.  Neuroprotection and brain cholesterol biosynthesis in Huntington's disease.

Authors:  Marta Valenza; Elena Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-31       Impact factor: 11.205

Review 2.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

3.  IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1.

Authors:  J Aebischer; P Cassina; B Otsmane; A Moumen; D Seilhean; V Meininger; L Barbeito; B Pettmann; C Raoul
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

4.  Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.

Authors:  Nikita Rudinskiy; Yulia Grishchuk; Anne Vaslin; Julien Puyal; André Delacourte; Harald Hirling; Peter G H Clarke; Ruth Luthi-Carter
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

5.  The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.

Authors:  Asad Jan; Ozgun Gokce; Ruth Luthi-Carter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

Review 6.  Potential therapeutic uses of BDNF in neurological and psychiatric disorders.

Authors:  Alan H Nagahara; Mark H Tuszynski
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

7.  Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration.

Authors:  Elpida Tsika; Maria Moysidou; Jing Guo; Mimi Cushman; Patrick Gannon; Raphael Sandaltzopoulos; Benoit I Giasson; Dimitri Krainc; Harry Ischiropoulos; Joseph R Mazzulli
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

8.  Synchrotron infrared microspectroscopy detecting the evolution of Huntington's disease neuropathology and suggesting unique correlates of dysfunction in white versus gray brain matter.

Authors:  Markus Bonda; Valérie Perrin; Bertrand Vileno; Heike Runne; Ariane Kretlow; László Forró; Ruth Luthi-Carter; Lisa M Miller; Sylvia Jeney
Journal:  Anal Chem       Date:  2011-09-22       Impact factor: 6.986

9.  A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.

Authors:  Marianne R Smith; Adeela Syed; Tamas Lukacsovich; Judy Purcell; Brett A Barbaro; Shane A Worthge; Stephen R Wei; Giuseppe Pollio; Letizia Magnoni; Carla Scali; Luisa Massai; Davide Franceschini; Michela Camarri; Marco Gianfriddo; Enrica Diodato; Russell Thomas; Ozgun Gokce; S J Tabrizi; Andrea Caricasole; Bernard Landwehrmeyer; Liliana Menalled; Carol Murphy; Sylvie Ramboz; Ruth Luthi-Carter; Goran Westerberg; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

Review 10.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.